BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 428905)

  • 1. The use of perfused rat intestine to characterise the glucagon-like immunoreactivity released into serosal secretions following stimulation by glucose.
    O'Connor FA; Conlon JM; Buchanan KD; Murphy RF
    Horm Metab Res; 1979 Jan; 11(1):19-23. PubMed ID: 428905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatographic pattern of gut glucagon-like immunoreactivity (GLI) in plasma before and during glucose absorption.
    Valverde I; Ghiglione M; Matesanz R; Casado S
    Horm Metab Res; 1979 May; 11(5):343-6. PubMed ID: 478429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of extractable gut glucagon-like immunoreactivity (GLI) and its lipolytic activity.
    Horigome K; Oneda A; Maruhama Y; Abe R; Kai Y
    Horm Metab Res; 1977 Sep; 9(5):370-4. PubMed ID: 924346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional release of glucagon-like immunoreactivity from the intestine of the cat.
    Frame CM
    Horm Metab Res; 1977 Mar; 9(2):117-20. PubMed ID: 863376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma glucagon-like immunoreactivity (GLI) in dogs.
    Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
    Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity.
    Ohneda A; Horigome K; Kai Y; Itabashi H; Ishii S; Yamagata S
    Horm Metab Res; 1976 May; 8(3):170-4. PubMed ID: 939462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of calcium and other salts upon the release of glucagon-like immunoreactivity from the gut.
    Böttger I; Faloona GR; Unger RH
    J Clin Invest; 1972 Apr; 51(4):831-6. PubMed ID: 5014613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal metabolism of gut glucagon-like immunoreactivity.
    Rovira A; López-Novoa JM; Zubiaur M; Matesanz R; Ghiglione M; Pascual JM; Valverde I
    Endocrinology; 1982 Jun; 110(6):2030-6. PubMed ID: 6896180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomeric specificity in the response of gut glucagon-like immunoreactive materials to glucose.
    Matsuyama T; Tanaka R; Shima K; Tarui S
    Horm Metab Res; 1979 Mar; 11(3):214-6. PubMed ID: 447202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity.
    Sundby F; Jacobsen H; Moody AJ
    Horm Metab Res; 1976 Sep; 8(5):366-71. PubMed ID: 976935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal rat intestinal cells in monolayer culture: a new in vitro system to study the glucagon-like immunoreactive peptides.
    Brubaker PL; Vranic M
    Endocrinology; 1987 May; 120(5):1976-85. PubMed ID: 3552626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in glucagon kinetics and processing in patients with acute pancreatitis.
    Tanjoh K; Tomita R; Ishikawa Y; Izumi T; Kinoshita K; Azuhata T
    Hepatogastroenterology; 2007 Jun; 54(76):1250-5. PubMed ID: 17629081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatographic pattern of extrapancreatic glucagon and glucagon-like immunoreactivity before and during stimulation by epinephrine and participation of glucagon in epinephrine-induced hepatic glucose overproduction.
    Lickley HL; Kemmer FW; Gray DE; Kovacevic N; Hatton TW; Perez G; Vranic M
    Surgery; 1981 Aug; 90(2):186-94. PubMed ID: 6114573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose.
    Karmann H; Mialhe P
    Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peculiar processing of glucagon and glucagon-related peptides in patients after pancreatectomy.
    Tanjoh K; Tomita R; Hayashi N
    Hepatogastroenterology; 2002; 49(45):825-32. PubMed ID: 12064000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic glucagon-like immunoreactivity in a pancreatectomized patient.
    Botha JL; Vinik AI; Child PT; Paul M; Jackson WP
    Horm Metab Res; 1977 May; 9(3):199-205. PubMed ID: 885471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peculiar glucagon processing in the intestine is the genesis of the paradoxical rise of serum pancreatic glucagon in patients after total pancreatectomy.
    Tanjoh K; Tomita R; Fukuzawa M; Hayashi N
    Hepatogastroenterology; 2003; 50(50):535-40. PubMed ID: 12749267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall distribution of glucagon-like immunoreactivity in the chicken retina: an immunohistochemical study with flat-mounts.
    Kuwayama Y; Ishimoto I; Fukuda M; Shimiza Y; Shiosaka S; Inagaki S; Senba E; Sakanaka M; Takagi H; Takatsuki K; Hara Y; Kawai Y; Tohyama M
    Invest Ophthalmol Vis Sci; 1982 May; 22(5):681-6. PubMed ID: 6281209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of plasma glucagon-like immunoreactivity (GLI) in patients with liver cirrhosis.
    Watanabe A; Hashimoto M; Higashi T; Kobayashi M; Nakatsukasa H; Yamauchi Y; Watanabe M; Fujiwara M; Nagashima H
    J Med; 1986; 17(2):95-108. PubMed ID: 3473162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.